9 Cheap Stocks to Buy According to Cathie Wood

Published on November 9, 2022 at 3:55 pm by Fahad Saleem in Hedge Funds, News

In this article, we discuss the 9 cheap stocks to buy according to Cathie Wood. If you want to skip our detailed analysis of these stocks, go directly to 4 Cheap Stocks to Buy According to Cathie Wood.

Cathie Wood’s hedge fund ARK Investment Management has been battered this year as investors exit growth stocks and move towards defensive plays. The hedge fund which made headlines with its explosive gains in 2021 saw its Innovation ETF crash by a whopping 60% this year. ARK’s assets under management, which had a total value of about $60 billion in February 2021, fell to just $16 billion as of the end of April this year.

However, Cathie Wood’s portfolio is still full of growth stocks that are not profitable and promise profits far into the future based on their disruptive products and services. Time and again she has claimed that she has a five-year horizon on these growth equities and investors should wait for these investments to come to fruition. At a conference in April this year, Wood claimed that ARK would rebound and gain as much as 50%.

In October, Cathie Wood said that the US auto debt market could face “serious losses,” citing data from September which showed a decrease in vehicle prices in the country. The growth investor thinks that gasoline-powered cars are losing traction as customers are starting to prefer electric vehicles.

In June, data from Bloomberg showed that ARK held $15.3 billion in assets across nine ETFs, a whopping 48% decrease from the start of 2022. Bloomberg said that it was the biggest collapse in assets among the 25 largest US issuers. However, surprisingly, most of this crash was due to the weak performance of ARK’s ETFs instead of investor exodus. The fund’s ETFs saw net inflows of $167 million in the period. This shows that growth investors who have a large risk appetite still trust Cathie Wood and are willing to wait until the market turns the corner. Only time would tell if Cathie Wood was right in betting huge money on small, loss-making companies that are working on “disruptive” technologies according to her.

Cathie Wood of ARK Investment Management

Our Methodology

For this article we used the third quarter portfolio of Cathie Wood’s hedge fund ARK Investment Management. We started from the top of the portfolio and picked 10 cheap stocks. Most of these stocks are priced under $35 as of October 31.

Cheap Stocks to Buy According to Cathie Wood

9. TuSimple Holdings Inc. (NASDAQ:TSP)

Tusimple Holdings is an autonomous trucking company that is trading around $5 as of October 24. This cheap stock is one of the favorites of Cathie Wood. As of the end of the third quarter of this year, ARK owns 16 million shares of the company which have a total worth of $122.35 million. While Tusimple has been battered in 2022 like other growth stocks in Cathie Wood’s portfolio, it can grow in the future when the market turns the corner because it’s operating in a high-growth domain.

In September, Truist Securities started covering TuSimple Holdings (NASDAQ:TSP) with a Buy rating and said the company is a leader in the emerging autonomous trucking because of its technology and its commercialization strategy to penetrate the $800 billion U.S. truck freight market.

8. UiPath Inc. (NYSE:PATH)

RPA software company UiPath Inc. (NYSE:PATH) is one of the cheapest growth stocks in Cathie Wood’s portfolio. ARK increased its hold in the company by 23% during the third quarter, ending the period with 46 million shares, worth $581.1 million. UiPath is down 70% this year. Recently, Barclays analyst Raimo Lenschow downgraded UiPath Inc. (NYSE:PATH), saying that the stock has become a “show-me” story as the company works to gain confidence and traction in the difficult environment.

In September, UiPath decreased its 2023 fiscal guidance, after which Mizuho downgraded the stock to Neutral from Buy and decreased the stock’s price target to $14 from $40.

Despite all of this, Cathie Wood believes the stock could rally. She initiated a new stake in UiPath Inc. (NYSE:PATH) in the second quarter of 2021 by buying 11.8 million shares.

Billionaire Jim Simons has a $99 million stake in UiPath as of the end of the second quarter of this year. Philippe Laffont’s Coatue Management is also an important shareholder in the company, with a $77 million stake as of the end of the June quarter.

7. Exact Sciences Corporation (NASDAQ:EXAS)

Exact Sciences Corporation (NASDAQ:EXAS) is a Wisconsin-based molecular genetics company that is working on technologies related to early detection of cancers. Cathie Wood bought a stake in the company during the third quarter of 2020 with 529,000 shares. As of the end of the third quarter, ARK’s stake in the company stood at 17.56 million shares, which had a value of $570.6 million.

In August, Credit Suisse analyst Dan Leonard started covering Exact Sciences Corporation (NASDAQ:EXAS) with an Outperform rating and a $55 price target. The analyst noted that Exact Sciences’ positions in the non-invasive colorectal cancer screening market is “durable.” The analyst also said that the upcoming catalysts from the pipeline can offset the risks coming from multi-cancer testing and minimal residual disease monitoring.

However, in October, Craig-Hallum analyst Alex Nowak downgraded Exact Sciences Corporation (NASDAQ:EXAS) to Hold from Buy with a price target of $35, down from $60.

As of the end of the second quarter, 28 hedge funds tracked by Insider Monkey had stakes in Exact Sciences Corporation (NASDAQ:EXAS). The total value of these stakes was about $1 billion. Ken Griffin’s Citadel Investment Group is also one of the largest stakeholders of the company. The fund owns a massive $99.6 million stake in the company.

Here is what RiverPark Large Growth Fund has to say about Exact Sciences Corporation in its Q4 2021 investor letter:

“Exact Sciences: Exact Sciences Corporation (NASDAQ:EXAS) shares declined on a disappointing recovery in Cologuard screening due to COVID. Despite continued revenue growth from Precision Oncology and COVID testing, and Cologuard screening revenue growth of 30%, COVID restrictions limited access to physicians’ offices for the company’s and its Pfizer Joint Venture sales force as well as causing a severe drop off of in-person wellness visits.

In the last year, Exact Sciences Corporation (NASDAQ:EXAS) has also pivoted the company significantly from its single cancer screening tests (Cologuard for colon cancer and Oncotype for breast cancer) to multi-cancer screening through its Thrive acquisition, and to minimal residual disease and recurrence monitoring through its Ashion and Tardis acquisitions. Through this pivot, Exact has tripled its market opportunity from $20 billion to $60 billion.”

6. Fate Therapeutics, Inc. (NASDAQ:FATE)

Fate Therapeutics is one of the best cheap stocks to buy according to Cathie Wood. The stock is hovering around $19 as of October 24. Cathie Wood’s ARK owns 11.7 million shares of the company as of the end of the September quarter. The total worth of these shares was $261.21 million. In August, Fate Therapeutics (NASDAQ:FATE) gained after Wells Fargo resumed its coverage with an Overweight rating. Wells Fargo analyst James Shin cited two growth catalysts coming in the fourth quarter of 2022 for the rating.

On October 10, Canaccord analyst Bill Maughan started covering Fate Therapeutics (NASDAQ:FATE) with a Buy rating and $42 price target. The analyst said in a note to investors that Fate Therapeutics (NASDAQ:FATE) is one of the most advanced natural killer cell companies.

Hedge fund sentiment, however, is declining for Fate Therapeutics (NASDAQ:FATE). A total of 23 hedge funds tracked by Insider Monkey had stakes in the company at the end of the June quarter, down from 31 funds in the first quarter.

Billionaire Izzy Englander’s Millennium Management owns an $18 million stake in the company as of the end of the second quarter. However, the biggest stakeholder of the firm at the end of June was Redmile Group of Jeremy Green. The hedge fund reported owning a $321 million stake in the company.

5. PagerDuty, Inc. (NYSE:PD)

Cathie Wood has been holding stakes in the SaaS-based incident response platform company PagerDuty, Inc. (NYSE:PD) since the first quarter of 2020. As of the end of the third quarter of this year, ARK had 10.8 million shares of the company. The total worth of these shares was about $250 million. In September, PagerDuty (NYSE:PD) jumped after posting strong quarterly results and receiving bullish comments from the Wall Street. Investment firm Monness, Crespi, Hardt analyst Brian White said that the strong results were welcomed by investors. However, the analyst, who has a Neutral rating on the stock, said that the enthusiasm could be “fleeting.” The analyst said that while PagerDuty, Inc. (NYSE:PD) has a “large opportunity” in the real-time digital ops market, the current state of the economy and geopolitical landscape could result in headwinds down the road.

As of the end of the second quarter of this year, 22 hedge funds tracked by Insider Monkey had stakes in the company, compared to 26 funds a quarter earlier. Robert G. Moses’ RGM Capital was among the notable shareholders of the company, with a stake worth $94.6 million.

Click to continue reading and see 4 Cheap Stocks to Buy According to Cathie Wood.

AI Fire Sale: Insider Monkey’s #1 AI Stock Pick Is On A Steep Discount

Published on May 1, 2024 at by Inan Dogan, PhD

Artificial intelligence is the greatest investment opportunity of our lifetime. The time to invest in groundbreaking AI is now, and this stock is a steal!

The whispers are turning into roars.

Artificial intelligence isn’t science fiction anymore.

It’s the revolution reshaping every industry on the planet.

From driverless cars to medical breakthroughs, AI is on the cusp of a global explosion, and savvy investors stand to reap the rewards.

Here’s why this is the prime moment to jump on the AI bandwagon:

Exponential Growth on the Horizon: Forget linear growth – AI is poised for a hockey stick trajectory.

Imagine every sector, from healthcare to finance, infused with superhuman intelligence.

We’re talking disease prediction, hyper-personalized marketing, and automated logistics that streamline everything.

This isn’t a maybe – it’s an inevitability.

Early investors will be the ones positioned to ride the wave of this technological tsunami.

Ground Floor Opportunity: Remember the early days of the internet?

Those who saw the potential of tech giants back then are sitting pretty today.

AI is at a similar inflection point.

We’re not talking about established players – we’re talking about nimble startups with groundbreaking ideas and the potential to become the next Google or Amazon.

This is your chance to get in before the rockets take off!

Disruption is the New Name of the Game: Let’s face it, complacency breeds stagnation.

AI is the ultimate disruptor, and it’s shaking the foundations of traditional industries.

The companies that embrace AI will thrive, while the dinosaurs clinging to outdated methods will be left in the dust.

As an investor, you want to be on the side of the winners, and AI is the winning ticket.

The Talent Pool is Overflowing: The world’s brightest minds are flocking to AI.

From computer scientists to mathematicians, the next generation of innovators is pouring its energy into this field.

This influx of talent guarantees a constant stream of groundbreaking ideas and rapid advancements.

By investing in AI, you’re essentially backing the future.

The future is powered by artificial intelligence, and the time to invest is NOW.

Don’t be a spectator in this technological revolution.

Dive into the AI gold rush and watch your portfolio soar alongside the brightest minds of our generation.

This isn’t just about making money – it’s about being part of the future.

So, buckle up and get ready for the ride of your investment life!

Act Now and Unlock a Potential 10,000% Return: This AI Stock is a Diamond in the Rough (But Our Help is Key!)

The AI revolution is upon us, and savvy investors stand to make a fortune.

But with so many choices, how do you find the hidden gem – the company poised for explosive growth?

That’s where our expertise comes in.

We’ve got the answer, but there’s a twist…

Imagine an AI company so groundbreaking, so far ahead of the curve, that even if its stock price quadrupled today, it would still be considered ridiculously cheap.

That’s the potential you’re looking at. This isn’t just about a decent return – we’re talking about a 10,000% gain over the next decade!

Our research team has identified a hidden gem – an AI company with cutting-edge technology, massive potential, and a current stock price that screams opportunity.

This company boasts the most advanced technology in the AI sector, putting them leagues ahead of competitors.

It’s like having a race car on a go-kart track.

They have a strong possibility of cornering entire markets, becoming the undisputed leader in their field.

Here’s the catch (it’s a good one): To uncover this sleeping giant, you’ll need our exclusive intel.

We want to make sure none of our valued readers miss out on this groundbreaking opportunity!

That’s why we’re slashing the price of our Premium Readership Newsletter by a whopping 75%.

For a ridiculously low price of just $24, you can unlock a year’s worth of in-depth investment research and exclusive insights – that’s less than a single restaurant meal!

Here’s why this is a deal you can’t afford to pass up:

The Name of the Game-Changing AI Stock: Our in-depth report dives deep into our #1 AI stock’s groundbreaking technology and massive growth potential.
Ad-Free Browsing: Enjoy a year of investment research free from distracting banner and pop-up ads, allowing you to focus on uncovering the next big opportunity.
Lifetime Money-Back Guarantee: If you’re not absolutely satisfied with our service, we’ll provide a full refund ANYTIME, no questions asked.

Space is Limited! Only 1000 spots are available for this exclusive offer. Don’t let this chance slip away – subscribe to our Premium Readership Newsletter today and unlock the potential for a life-changing investment.

Here’s what to do next:

Head over to our website and subscribe to our Premium Readership Newsletter for just $24.
Enjoy a year of ad-free browsing, exclusive access to our in-depth report on the revolutionary AI company, and the upcoming issues of our Premium Readership Newsletter over the next 12 months.
Sit back, relax, and know that you’re backed by our ironclad lifetime money-back guarantee.

Don’t miss out on this incredible opportunity! Subscribe now and take control of your AI investment future!

Subscribe Now!

A New Dawn is Coming to U.S. Stocks

Published on May 2, 2024 at by Insider Monkey Staff

I work for one of the largest independent financial publishers in the world – representing over 1 million people in 148 countries.

We’re independently funding today’s broadcast to address something on the mind of every investor in America right now…

Should I put my money in Artificial Intelligence?

Here to answer that for us… and give away his No. 1 free AI recommendation… is 50-year Wall Street titan, Marc Chaikin.

Marc’s been a trader, stockbroker, and analyst. He was the head of the options department at a major brokerage firm and is a sought-after expert for CNBC, Fox Business, Barron’s, and Yahoo! Finance…

But what Marc’s most known for is his award-winning stock-rating system. Which determines whether a stock could shoot sky-high in the next three to six months… or come crashing down.

That’s why Marc’s work appears in every Bloomberg and Reuters terminal on the planet…

And is still used by hundreds of banks, hedge funds, and brokerages to track the billions of dollars flowing in and out of stocks each day.

He’s used this system to survive nine bear markets… create three new indices for the Nasdaq… and even predict the brutal bear market of 2022, 90 days in advance.

Click to continue reading…

Insider Monkey Ads

Markets

Insider Trading

Hedge Funds

Retirement

Opinion

Log In

Sign Up